title: Microsatellite instability is correlated with lymph node-positive breast cancer.
abstract: We analyzed 81 cases of primary breast carcinoma and 7 cases of fibroadenoma for microsatellite instability at eight loci. Twenty-seven cases (33.3%) manifested aberrant microsatellite alleles: 7 (8.6%) at one locus and 20 (24.7%) at two or more loci [tumors with replication error-positive (RER+) phenotype]. No evidence of microsatellite instability was observed in fibroadenomas. We investigated correlations between RER+ phenotype and clinicopathological characteristics of the carcinomas. The RER+ phenotype was statistically associated with large tumor diameter; of 19 RER+ tumors with measured size, 16 were > 2 cm, compared to 28 of 58 tumors with no evidence of microsatellite instability or with shifts in allele sizes limited to one locus (P </= 0.005, chi2 test). Consistently, there was also a strong statistical association between RER+ phenotype and lymph node metastasis; 14 of 19 RER+ tumors with known lymph node status were N+, compared to 15 of 59 tumors with no evidence of microsatellite instability or with allele shifts limited to one locus (P </= 0.0002, chi2 test). Correlations with age of patients, proliferative activity, histotype (ductal versus lobular), and grade of differentiation were not statistically significant, although the RER+ phenotype was more frequent in lobular and high-grade ductal carcinomas, in carcinomas with high proliferative activity, and in carcinomas from patients </=50 years. Data concerning cancer(s) in first and/or second degree relatives were available for 66 cases, including 33 positive and 33 negative for family history of cancer. No correlations were detected between RER+ phenotype and family history of cancer. In conclusion, our results indicate that in breast cancer, microsatellite instability is associated with clinicopathological parameters that are considered predictors of recurrent disease and aggressive behavior.
authors.affiliation: Departments of Experimental Medicine, University "La Sapienza," 00161 Rome.
authors.forename: L
authors.initials: L
authors.lastname: De Marchis
authors.forename: A
authors.initials: A
authors.lastname: Contegiacomo
authors.forename: C
authors.initials: C
authors.lastname: D'Amico
authors.forename: R
authors.initials: R
authors.lastname: Palmirotta
authors.forename: C
authors.initials: C
authors.lastname: Pizzi
authors.forename: L
authors.initials: L
authors.lastname: Ottini
authors.forename: P
authors.initials: P
authors.lastname: Mastranzo
authors.forename: M
authors.initials: M
authors.lastname: Figliolini
authors.forename: G
authors.initials: G
authors.lastname: Petrella
authors.forename: C
authors.initials: C
authors.lastname: Amanti
authors.forename: P
authors.initials: P
authors.lastname: Battista
authors.forename: A R
authors.initials: AR
authors.lastname: Bianco
authors.forename: L
authors.initials: L
authors.lastname: Frati
authors.forename: A
authors.initials: A
authors.lastname: Cama
authors.forename: R
authors.initials: R
authors.lastname: Mariani-Costantini
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D005819:Genetic Markers / Q000235:genetics; D006801:Humans; D008207:Lymphatic Metastasis; D018895:Microsatellite Repeats / Q000235:genetics*; D008875:Middle Aged
chemical_list: D005819:Genetic Markers